GRACELL BIOTECHNOLOGIES
Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer. The company's therapy offers cellular therapeutics for the patients suffered from hematological malignancy, solid tumor or degenerative disease, enabling healthcare providers to cure their patients and improve their lives.
GRACELL BIOTECHNOLOGIES
Industry:
Biotechnology Health Care Medical
Founded:
2017-01-01
Address:
Suzhou, Jiangsu, China
Country:
China
Website Url:
http://www.gracellbio.com
Total Employee:
51+
Status:
Active
Total Funding:
185 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Nginx IPv6 COVID-19 IIS Sectigo SSL Sectigo Domain SSL
Similar Organizations
Reborna Biosciences
Reborna Biosciences is a research and development start-up focusing on the field of rare genetic diseases.
Ruiyi Biotechnology (Realbio Technology)
Ruiyi Biotechnology is a national high-tech enterprise.
Fore Biotherapeutics
We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Nalagenetics
Nalagenetics is a biotechnology company that provides genetic testing services.
Neuron23
Neuron23 is a developer of drugs intended to treat Parkinson's disease and Alzheimer's disease.
Newsoara
Newsoara is a biomedical technology developer that specializes in the development of medical devices.
NanoHealth
NanoHealth is changing the face of urban health in India.
Neukio Biotherapeutics
Neukio Biotherapeutics is a developer of allogenic immune cell therapies for treatment of cancer.
Veneno Technologies
Veneno Technologies is a research and development of therapeutic disulfide-rich peptides and medicines.
Vedanta Biosciences
Vedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.
MXB Biotechnologies
MXB Biotechnologies is a tumor pathology immunohistochemical diagnostic reagents developer company.
Microread
Microread is a provider of life science institutions integrating R&D, production and operation.
Lily MedTech
Lily MedTech is conducting research on imaging systems for breast cancer.
Luxna Biotech
Luxana Biotech is established to contribute to medical treatment for suffering patients, .
Lansion Biotechnology
Lansion Biotechnology is specialized in research & development, production, sell, services of in vitro diagnostic reagents and devices.
Anastasis Biotec
Anastasis Biotec is a developer of a novel and proprietary treatment made for patients with cancers.
Afferent Technologies
Afferent Technologies is a developer of novel instrumentation for neuroscience and neurology.
AmbAgon Therapeutics
AmbAgon Therapeutics is a developer of cancer molecule therapeutics.
Azura Ophthalmics
Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD.
Aenitis Technologies
Aenitis Technologies is a French start-up resulting from the work of Mauricio HOYOS
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Earli
Earli is a developer of cancer treatment devices designed to search for natural biomarkers.
Entrada Therapeutics
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
Burning Rock Biotech
Burning Rock Biotech focuses on providing individualized cancer treatment guidance for the patients.
Bio-Raid
Bio-Raid is a biological cell immunotherapy service provider company.
Fosun Kite Biotechnology
Fosun Kite Biotechnology develops immune cell therapy products.
CanSinoBIO
Tianjin CanSino Biotechnology Inc. is a vaccine manufacturing facility.
T-knife
T-knife is a developer of T cell receptors intended for T cell therapy of cancer.
UniXell
UniXell develops cell therapies for the treatment of cancer and neurodegenerative disorders.
Qitan Technology
Qitan Technology is a Developer of a genome sequencing technology.
QTC Care
QTC Care is a platform dedicated to the one-stop management of cancer.
KORTUC
KORTUC is a radiosensitizer that enhances the effectiveness of radiation therapy for cancer.
Sana Biotechnology
Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.
Surgical Innovation Associates
Surgical Innovation Associates is a developer of implantable polymeric surgical devices for plastic, reconstructive, and general surgery.
Seraph Biosciences
Seraph Biosciences is a developer of real-time pathogen detection systems used to treat infections.
Spatial Genomics
Spatial Genomics is a developer of sequential fluorescence in situ hybridization (seqFISH) technology.
Sealantis
Sealantis is a developer of an alginate-based tissue adhesive technology platform.
Dima Biotech
Dima Biotech is a cancer immunotherapy and monoclonal antibody developer.
Durin Technologies
Durin Technologies is a developer of Alzheimer's diagnostic test intended to measure certain auto antibodies in serum.
Home Biosciences
Home Biosciences is a European venture builder dedicated to biotech.
Health Biotech
Health Biotech is a mass spec research and development company.
Grail
Grail develops a pan-cancer screening test designed to detect cancers at an early stage.
GenomiCare Biotechnology
GenomiCare Biotechnology is a Chinese precision cancer medicine service company
OncoSenX
OncoSenX is a developer of transient gene therapies designed for solid tumors.
Omniscope
We read your immune system to intercept diseases.
OrthoAccel Technologies
OrthoAccel Technologies develops and manufactures an acceleration device for orthodontics.
Xbiome
Xbiome is a developer of microbial pharmaceuticals designed to treat microecological intestinal disorders.
Cellusion
Cellusion is a developer of corneal endothelial regenerative medicine intended to improve world visibility.
Cyrus Biotechnology
Cyrus Biotechnology is a developer of Rosetta software platform that solves drug discovery problems.
C4U Corporation
C4U Corporation is a developer of a genome editing technology.
Pilot Biotechnology
Pilot Biotechnology is an industrial biotechnology company engaged in the development, production, and sales of health care products.
Panomic Biomedical Technology
Panomic Biomedical Technology is a developer of detection, analysis, and processing platforms for metabolomics.
PeLeMed
PeLeMed is a drug development company working on the discovery of anti-cancer drugs.
Yuce Biological Technology
Yuce Biological Technology is a biotechnology developer which focuses on cancer diagnosis through gene detection.
Current Employees Featured
Founder
Stock Details
Investors List
Temasek Holdings
Temasek Holdings investment in Series C - Gracell Biotechnologies
King Star Capital
King Star Capital investment in Series C - Gracell Biotechnologies
OrbiMed
OrbiMed investment in Series C - Gracell Biotechnologies
Morningside Venture Partners
Morningside Venture Partners investment in Series C - Gracell Biotechnologies
Vivo Capital
Vivo Capital investment in Series C - Gracell Biotechnologies
Wellington Management
Wellington Management investment in Series C - Gracell Biotechnologies
Lilly Asia Ventures
Lilly Asia Ventures investment in Series C - Gracell Biotechnologies
King Star Capital
King Star Capital investment in Series B - Gracell Biotechnologies
Temasek Holdings
Temasek Holdings investment in Series B - Gracell Biotechnologies
Chengdu Miaoji Medical Technology
Chengdu Miaoji Medical Technology investment in Series B - Gracell Biotechnologies
Key Employee Changes
Official Site Inspections
http://www.gracellbio.com Semrush global rank: 2.12 M Semrush visits lastest month: 9.62 K
- Host name: 47.251.37.55
- IP address: 47.251.37.55
- Location: San Mateo United States
- Latitude: 37.5517
- Longitude: -122.33
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94402
More informations about "Gracell Biotechnologies"
About Us | Gracell
Who We Are. Gracell Biotechnologies is a global clinical-stage biopharmaceutical company dedicated to discovering and developing innovative cell therapies.See details»
Gracell | Pioneering Next Generation CAR-T Therapies
Our Mission We are a global clinical-stage biopharmaceutical company dedicated to discovering and developing innovative cell therapies that aim to address major industry challenges and fulfill unmet medical needs in the treatment of cancer …See details»
About Us | Gracell
She was a partner at Deloitte China, having worked in Beijing, Hong Kong and San Francisco. Ms. Hayes later served as the China expert and led inspections for the Public Company …See details»
AstraZeneca to acquire Gracell, furthering cell therapy ambition …
Dec 26, 2023 The proxy statement and other relevant materials in connection with the proposed transaction (when they become available), and any other documents filed or furnished with the …See details»
Gracell Biotechnologies - Crunchbase Company Profile & Funding
Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer. The company's therapy offers cellular therapeutics for the patients suffered from hematological …See details»
Gracell Biotechnologies - LinkedIn
As a member of the AstraZeneca Group, Gracell Biotechnologies is a global clinical-stage biopharmaceutical company dedicated to discovering and developing novel autologous and …See details»
Gracell Biotechnologies | LinkedIn
Gracell Biotechnologies | 4,869 followers on LinkedIn. A Member of the AstraZeneca Group | As a member of the AstraZeneca Group, Gracell Biotechnologies is a global clinical-stage …See details»
Gracell Biotechnologies Acquisition Completed | Gracell
Feb 22, 2024 Gracell Biotechnologies Acquisition Completed Feb 22, 2024 . SAN DIEGO and SUZHOU, China and SHANGHAI, China, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Gracell …See details»
Gracell Biotechnologies Appoints Veteran BioPharma Executive Dr.
Jul 19, 2022 Follow @GracellBio on LinkedIn. Cautionary Noted Regarding Forward-Looking Statements. Statements in this press release about future expectations, plans and prospects, …See details»
Press Releases - Gracell Bio
Dec 26, 2023 Follow @GracellBio on LinkedIn. Additional Information and Where to Find It In connection with the proposed transaction, the Company intends to file or furnish relevant …See details»
Press Releases | Gracell
Dec 11, 2023 Gracell Biotechnologies Acquisition Completed SAN DIEGO and SUZHOU, China and SHANGHAI, China, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. …See details»
AstraZeneca to acquire Gracell, furthering cell therapy ambition …
Dec 26, 2023 The proxy statement and other relevant materials in connection with the proposed transaction (when they become available), and any other documents filed or furnished with the …See details»
Gracell Biotechnologies to Present Updated Clinical Data on …
Please visit www.gracellbio.com . Follow @GracellBio on LinkedIn . Cautionary Noted Regarding Forward-Looking Statements Statements in this press release about future expectations, plans …See details»
Press Releases - Gracell Bio
Sep 19, 2023 Follow @GracellBio on LinkedIn. Cautionary Noted Regarding Forward-Looking Statements Statements in this press release about future expectations, plans, and prospects, …See details»
Gracell Biotechnologies Wins Overall Immunology Solution of the …
Nov 8, 2023 Third annual BioTech Breakthrough Award recognizes excellence in life science and biotechnology solutions, services and companies GC012F, a FasTCAR-enabled …See details»
Gracell Biotechnologies Wins Overall Immunology Solution of
Nov 8, 2023 The BioTech Breakthrough Awards program was founded in 2021 by BioTech Breakthrough, a leading independent market intelligence organization that evaluates and …See details»
Gracell Biotechnologies Unveils Innovation Center in U.S. | Gracell
Jan 12, 2022 Follow @GracellBio on LinkedIn. Cautionary Noted Regarding Forward-Looking Statements Statements in this press release about future expectations, plans and prospects, …See details»
Press Releases - Gracell Bio
Jul 23, 2020 Gracell Expands Executive Team by Appointment of CMO Dr. Martina Sersch and CFO Dr. Kevin Xie Jul 23, 2020 . SHANGHAI and SUZHOU, China, July 23, 2020 …See details»
Scientific Publications | Gracell
Published: June, 2024 Source: 2024 EHA Annual Meeting A phase I open-label single-arm study of dual targeting BCMA and CD19 FasTCAR-T AZD0120 (GC012F) as first-line therapy for …See details»
Our Pipeline | Gracell
We are developing a rich pipeline of differentiated autologous and allogeneic product candidates. We seek to develop our product candidates by leveraging our relationships with clinicians and …See details»